ReleaseWire

Global Markets Direct's, 'Signature Therapeutics, Inc - Product Pipeline Review - 2014', provides an overview of the Signature Therapeutics, Inc's pharmaceutical research and development focus.

Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages. First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin.

AMD is defined as the deterioration of the eye's macula. The macula is a small area in the retina that is responsible for central vision. The exact etiology of AMD is unknown. There are two types of macular degeneration: wet and dry. Wet AMD occurs when tiny abnormal blood vessels begin growing behind the retina toward the macula. Dry AMD occurs when small, yellowish deposits called drusen begin accumulating beneath the macula. While a number of treatments are available for wet AMD, there is no treatment available at the moment for dry AMD.

Global Markets Direct's, 'Helsinn Healthcare S.A. - Product Pipeline Review - 2014', provides an overview of the Helsinn Healthcare S.A.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Chronic Pancreatitis Pain Global Clinical Trials Review, H1, 2014" provides data on the Chronic Pancreatitis Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Pancreatitis Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Pancreatitis Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Advanced Accelerator Applications S.A. (“AAA” or “the Company”), an international specialist in Molecular Nuclear Medicine (MNM), is pleased to announce its results for the financial year 2013, with sales of €53.8 million (+31.77% vs. 2012).

More than 55 diseases have been linked to gluten, the protein found in wheat, rye, and barley.The most common symptom of a gluten allergy is stomach bloating after eating a meal that contains gluten. Other symptoms may include skin that resembles chicken skin on the arms, fatigue after meals, dizziness, migraine headaches, swelling or pain in joints, anxiety, depression and mood swings. Many people have overcome their gluten allergy by following a gluten free diet.

Global Markets Direct's, 'ChemoCentryx, Inc. - Product Pipeline Review - 2014', provides an overview of the ChemoCentryx, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Thalassemia - Pipeline Review, H1 2014', provides an overview of the Thalassemia's therapeutic pipeline.

Global Markets Direct's, 'JW Pharmaceutical Corporation - Product Pipeline Review - 2014', provides an overview of the JW Pharmaceutical Corporation's pharmaceutical research and development focus.

Global Markets Direct's, 'Maruho Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Maruho Co., Ltd.'s pharmaceutical research and development focus.

Actinium Pharmaceuticals, Inc.,("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced the addition of M. Yair Levy, MD of Baylor to its Scientific Advisory Board (SAB) for Iomab™-B. Iomab™-B, the Company’s lead radioimmunotherapy asset, is entering a Phase 3 trial to potentially address the rapid mortality and significant unmet medical need for older patients with acute myeloid leukemia (AML) and well as in other cancer indications.

The Covance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Covance, Inc. since January 2007.

Global Markets Direct's, 'Bacterial Vaginosis - Pipeline Review, H1 2014', provides an overview of the Bacterial Vaginosis's therapeutic pipeline.

Global Markets Direct's, 'ARA Healthcare Pvt. Ltd. - Product Pipeline Review - 2014', provides an overview of the ARA Healthcare Pvt. Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Nonmelanomatous Skin Cancer - Pipeline Review, H1 2014', provides an overview of the Nonmelanomatous Skin Cancer's therapeutic pipeline.

Global Markets Direct's, 'Gastric Ulcers - Pipeline Review, H1 2014', provides an overview of the Gastric Ulcers's therapeutic pipeline.

GlobalData's clinical trial report, "Convulsions Global Clinical Trials Review, H1, 2014" provides data on the Convulsions clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Convulsions. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Convulsions. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Endometriosis is a common female health condition where the endometrial tissue, which is usually found inside the lining of the uterus, appear and grows outside the uterine cavity. Endometriosis mostly occurs in the fallopian tubes, ovaries, outer surface of the uterus, pelvic cavity, vagina, cervix, and bladder. Endometriosis has rarely been reported in more distant parts of the body such as the lungs, brain, and skin. The most common symptoms associated with endometriosis are pelvic pain, dysmenorrhea, excessive bleeding, and lower abdominal pain. Some of the uncommon symptoms of endometriosis are rectal bleeding and hematuria. The detection of endometriosis in women is difficult because of the common symptoms associated with it. Endometriosis can be diagnosed by laparoscopy, ultrasound, pelvic exam, and biopsy of the inner lining of the uterus. In a biopsy, the tissues from the inner lining of the uterus of the patient are taken and tested using the biomarkers for the presence of endometriosis. Endometriosis is an incurable disease and relapses after the primary treatment. Currently, the treatment options for endometriosis include the usage of hormone therapy and analgesics to control the disease.

Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose in the initial stages because the symptoms are similar to that of gastric disorders like bloating, abdominal discomfort, difficulty in eating in the early stage and nausea, vomiting, constipation and diarrhoea in the later stages. It is often diagnosed in advanced stages when the metastasis has set in because the diagnostic techniques are not well-developed. Ovarian cancer can be treated by using chemotherapy, targeted therapy, and surgery. Although the market has a limited number of drugs for the treatment of ovarian cancer currently, a strong product pipeline is in development for the forecast period.

Global Markets Direct's, 'Newron Pharmaceuticals S.p.A. - Product Pipeline Review - 2014', provides an overview of the Newron Pharmaceuticals S.p.A.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Bulimia Nervosa Global Clinical Trials Review, H1, 2014" provides data on the Bulimia Nervosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bulimia Nervosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bulimia Nervosa. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Nootropics are a relatively new class of drugs found to be effective in enhancing particular functions in the brain by increasing the availability of key chemicals used in everyday brain function. Since their discovery the variety and versatility of these drugs has expanded rapidly, as has the market for them. With such demand, there are now businesses setting out to take advantage of people’s desire for these products with ineffective supplements. Nootropic Supplement Review has been created to help people tell the difference between the good, the bad and the great. Their latest review is of a popular and exciting supplement, Noopept.

Global Markets Direct's, 'Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Regeneron Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, '4SC AG - Product Pipeline Review - 2014', provides an overview of the 4SC AG's pharmaceutical research and development focus.